Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Creative Medical Technology Holdings (CELZ) over the last 15 years, with Q3 2025 value amounting to -$1.2 million.

  • Creative Medical Technology Holdings' Cash from Operations fell 1856.97% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.9 million, marking a year-over-year decrease of 1184.9%. This contributed to the annual value of -$5.3 million for FY2024, which is 3396.4% up from last year.
  • Latest data reveals that Creative Medical Technology Holdings reported Cash from Operations of -$1.2 million as of Q3 2025, which was down 1856.97% from -$1.2 million recorded in Q2 2025.
  • Creative Medical Technology Holdings' 5-year Cash from Operations high stood at -$222139.0 for Q2 2021, and its period low was -$3.8 million during Q1 2023.
  • Over the past 5 years, Creative Medical Technology Holdings' median Cash from Operations value was -$1.2 million (recorded in 2025), while the average stood at -$1.4 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first plummeted by 213793.21% in 2021, then surged by 7665.41% in 2024.
  • Over the past 5 years, Creative Medical Technology Holdings' Cash from Operations (Quarter) stood at -$1.2 million in 2021, then crashed by 209.23% to -$3.6 million in 2022, then surged by 47.23% to -$1.9 million in 2023, then fell by 2.88% to -$1.9 million in 2024, then surged by 40.06% to -$1.2 million in 2025.
  • Its last three reported values are -$1.2 million in Q3 2025, -$1.2 million for Q2 2025, and -$1.6 million during Q1 2025.